Business

SBC Medical Announces Capital Strategy: Effectiveness of Form S-3 Registration Statement and Approval of Up to $20 Million Share Repurchase Program

IRVINE, Calif.--(BUSINESS WIRE)-- SBC Medical Group Holdings Incorporated (NASDAQ: SBC) (the “Company”), a global provider of comprehensive consulting and

articleSbc Medical Group Holdings IncorporatedDecember 31, 20255/company/sbc-communications-inc/news/sbc-medical-announces-capital-strategy-effectiveness-of-form-s-3-registration-statement-and-approval-of-up-to-dollar20-million-share-repurchase-program
SBC Medical Announces Capital Strategy: Effectiveness of Form S-3 Registration Statement and Approval of Up to $20 Million Share Repurchase Program

About this update from Sbc Medical Group Holdings Incorporated

[{"type":"text","content":" IRVINE, Calif.--(BUSINESS WIRE)--\nSBC Medical Group Holdings Incorporated (NASDAQ: SBC) (the “Company”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced an updated capital strategy for future growth, which includes the filing of a Form S-3 registration statement with the U.S. Securities and Exchange Commission (SEC) and a share repurchase program. The Company remains committed to maximizing corporate value and improving liquidity of its common stock while carefully considering market impact.\n\n\nEffectiveness of Form S-3 (Shelf Registration)\n\n\nThe Company’s Form S-3 Registration Statement, which was declared effective by the SEC on December 30, 2025, enables the Company to offer and sell, from time to time in one or more offerings, up to $50 million of common stock or preferred stock on a primary basis. The Company is not selling any securities from the shelf registration statement at this time, and if the Company decides to raise capital in a future offering using the shelf registration statement, the Company will describe the specific details of that future offering in a prospectus supplement that is filed with the SEC. The Company believes that a shelf registration on Form S-3 will provide greater flexibility to raise capital in the future, to facilitate growth, including domestic and international M&A, and supports its efforts to increase its public float.\n\n\nAdditionally, the Form S-3 covers securities related to the Company’s business combination transaction that closed on September 17, 2024, including securities being sold by selling securityholders, which were previously registered on the Company’s registration statement on Form S-1.\n\n\nThis press release shall not constitute an offer to sell nor the solicitation of an offer to buy the securities that are registered on the Form S-3, nor shall there be any sale of such securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities law of any such state. Any offer of securities will occur solely by means of the prospectus included in the registration statement and one or more prospectus supplements that would be issued at the time of the offering, as applicable.\n\n\nApproval of Share Repurchase Prog...

More updates from Sbc Medical Group Holdings Incorporated